Efficacy and safety of stem cells in the treatment of ischemic stroke: A meta-analysis.
Yu XiongXiumei GuoWen GaoChuhan KeXinyue HuangZhigang PanChunhui ChenHanlin ZhengWeipeng HuFeng ZhengHao YaoPublished in: Medicine (2024)
Stem cell therapy reduces mortality and improves the neurological prognosis of ischemic stroke patients. However, due to the different types of stem cells used and the limited data in the reported studies, the safety of clinical applications of stem cells in patients with ischemic stroke must be carefully evaluated. Future randomized controlled trials with large sample sizes from controlled cell sources are warranted to validate this finding.
Keyphrases
- stem cells
- cell therapy
- atrial fibrillation
- end stage renal disease
- randomized controlled trial
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- single cell
- cardiovascular disease
- electronic health record
- cardiovascular events
- mesenchymal stem cells
- current status
- coronary artery disease
- artificial intelligence
- study protocol
- data analysis
- patient reported
- double blind